Shares Of OHR Pharmaceuticals Soar 30% After Announcing Additional Positive Data For Wet AMD Drug
March 02, 2015 at 21:28 PM EST
OHR Pharmaceuticals announces that treatment with OHR-102 together with Lucentis produces better results than Lucentis alone.